176 related articles for article (PubMed ID: 24132873)
1. Performance of a motor task learned on levodopa deteriorates when subsequently practiced off.
Anderson ED; Horak FB; Lasarev MR; Nutt JG
Mov Disord; 2014 Jan; 29(1):54-60. PubMed ID: 24132873
[TBL] [Abstract][Full Text] [Related]
2. Dopamine Replacement Medication Does Not Influence Implicit Learning of a Stepping Task in People With Parkinson's Disease.
Paul SS; Schaefer SY; Olivier GN; Walter CS; Lohse KR; Dibble LE
Neurorehabil Neural Repair; 2018 Dec; 32(12):1031-1042. PubMed ID: 30409107
[TBL] [Abstract][Full Text] [Related]
3. Dopamine replacement improves motor learning of an upper extremity task in people with Parkinson disease.
Paul SS; Dibble LE; Olivier GN; Walter C; Duff K; Schaefer SY
Behav Brain Res; 2020 Jan; 377():112213. PubMed ID: 31526767
[TBL] [Abstract][Full Text] [Related]
4. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
[TBL] [Abstract][Full Text] [Related]
5. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
6. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
7. L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease.
Ghilardi MF; Feigin AS; Battaglia F; Silvestri G; Mattis P; Eidelberg D; Di Rocco A
Parkinsonism Relat Disord; 2007 Apr; 13(3):146-51. PubMed ID: 17055764
[TBL] [Abstract][Full Text] [Related]
8. Psychophysiological approach in Parkinson's disease: L-dopa effects on preprogramming and control activity.
Fattapposta F; Pierelli F; My F; Mostarda M; Del Monte S; Parisi L; Serrao M; Locuratolo N; Amabile G
Neurol Sci; 2002 Sep; 23 Suppl 2():S73-4. PubMed ID: 12548350
[TBL] [Abstract][Full Text] [Related]
9. Levodopa and the feedback process on set-shifting in Parkinson's disease.
Au WL; Zhou J; Palmes P; Sitoh YY; Tan LC; Rajapakse JC
Hum Brain Mapp; 2012 Jan; 33(1):27-39. PubMed ID: 21438075
[TBL] [Abstract][Full Text] [Related]
10. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
Kwak Y; Bohnen NI; Müller ML; Dayalu P; Burke DT; Seidler RD
Behav Brain Res; 2013 May; 245():128-36. PubMed ID: 23439215
[TBL] [Abstract][Full Text] [Related]
11. L-dopa effects on preprogramming and control activity in a skilled motor act in Parkinson's disease.
Fattapposta F; Pierelli F; My F; Mostarda M; Del Monte S; Parisi L; Serrao M; Morocutti A; Amabile G
Clin Neurophysiol; 2002 Feb; 113(2):243-53. PubMed ID: 11856629
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
[TBL] [Abstract][Full Text] [Related]
13. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
[TBL] [Abstract][Full Text] [Related]
14. Comparing kinematic changes between a finger-tapping task and unconstrained finger flexion-extension task in patients with Parkinson's disease.
Teo WP; Rodrigues JP; Mastaglia FL; Thickbroom GW
Exp Brain Res; 2013 Jun; 227(3):323-31. PubMed ID: 23686150
[TBL] [Abstract][Full Text] [Related]
15. Focusing effects of L-dopa in Parkinson's disease.
Ng B; Palmer S; Abugharbieh R; McKeown MJ
Hum Brain Mapp; 2010 Jan; 31(1):88-97. PubMed ID: 19585587
[TBL] [Abstract][Full Text] [Related]
16. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
Mongeon D; Blanchet P; Messier J
Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
[TBL] [Abstract][Full Text] [Related]
17. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients.
Buhmann C; Glauche V; Stürenburg HJ; Oechsner M; Weiller C; Büchel C
Brain; 2003 Feb; 126(Pt 2):451-61. PubMed ID: 12538411
[TBL] [Abstract][Full Text] [Related]
19. Effects of levodopa on motor sequence learning in Parkinson's disease.
Feigin A; Ghilardi MF; Carbon M; Edwards C; Fukuda M; Dhawan V; Margouleff C; Ghez C; Eidelberg D
Neurology; 2003 Jun; 60(11):1744-9. PubMed ID: 12796524
[TBL] [Abstract][Full Text] [Related]
20. Effects of levodopa on upper limb mobility and gait in Parkinson's disease.
Vokaer M; Azar NA; de Beyl DZ
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1304-7. PubMed ID: 12933941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
